UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): November 12,
2020
TOMI Environmental Solutions, Inc.
(Exact
name of registrant as specified in its charter)
|
Florida
|
|
000-09908
|
|
59-1947988
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
8430 Spires Way, Suite N Frederick, Maryland 21701
(Address
of principal executive offices) (Zip Code)
(800) 525-1698
(Registrant's
telephone number, including area code)
9454 Wilshire Boulevard, Penthouse, Beverly Hills, CA
90212
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company
as defined in as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging growth
company
☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Item 2.02 Results
of Operations and Financial Condition.
On November 12, 2020, TOMI Environmental Solutions, Inc.
issued a press release regarding its financial results for the
third quarter ended September 30, 2020. A copy of the press release
is attached to this Current Report on Form 8-K as Exhibit 99.1. No
additional information is included in this Current Report on Form
8-K.
The
information included in this Current Report on Form 8-K, including
the exhibit hereto, shall not be deemed “filed” for
purposes of, nor shall it be deemed incorporated by reference in,
any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except as expressly set forth by specific
reference in such a filing.
Item
9.01 Financial
Statements and Exhibits.
(d)
Exhibits.
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Press
release issued November 12, 2020
|
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
TOMI
ENVIRONMENTAL SOLUTIONS, INC.
|
|
|
|
|
|
|
Dated: November 12,
2020
|
By:
|
/s/ Halden
Shane
|
|
|
|
|
Halden
Shane
|
|
|
|
|
Chief Executive
Officer
|
|
EXHIBIT INDEX
|
Exhibit Number
|
|
Description
|
|
|
|
Press
release issued November 12, 2020
|
TOMI ENVIRONMENTAL SOLUTIONS, INC. REPORTS
THIRD QUARTER 2020 FINANCIAL RESULTS
FREDERICK, MD, November 12, 2020 (BUSINESS WIRE) —
TOMI
Environmental Solutions, Inc.®
(“TOMI”)
(NASDAQ:TOMZ), is a global company specializing in disinfection and
decontamination utilizing its premier Binary Ionization Technology
(BIT) platform through its SteraMist brand of products - a hydrogen
peroxide-based mist and fog comprised of ionized Hydrogen Peroxide
(iHP), announced its results for the third quarter of
2020.
TOMI Chief Executive Officer, Dr. Halden Shane stated, “We
are a company that strives for SteraMist to become the gold
standard in its industry, and I report another major milestone with
revenues exceeding $21 million for our current calendar year. The
third quarter also continued the trend of year over year revenue
growth as SteraMist continues to see widespread adoption. We have
been pleasantly surprised to see that new clients in a number of
the new verticals targeted by our commercial division are proving
to be faster in integrating SteraMist into their protocol compared
to blue-chip clients that adhere to stringent protocol and
procedures. On the other hand, the TOMI Service Network and
Healthcare Divisions faced persistent headwinds in the quarter as a
number of potential clients elected to continue to utilize harsh
chemical disinfectants and low-cost delivery systems. We anticipate
these industries will increasingly see negative affects of these
disinfectants and increasingly seek SteraMist to be their permanent
solution, a trend that we have already seen as we begin the fourth
quarter, as many of these companies are our either returning to, or
starting to use, SteraMist. We also continued to make strides on
the product development and intellectual property front with the
SteraBot and SteraPack which will provide more differentiation in
our product line and a competitive advantage in the marketplace.
Management is adding executive sales division leaders and executing
a plan for all divisions to grow consistently, both domestically
and internationally, as we strive to innovate for a safer
world”.
Financial Results for the Three Months Ended September 30, 2020
compared to September 30, 2019
●
Total net revenue was $4,292,000 compared to $1,600,000,
representing an increase of $2,692,000, or 168%.
●
SteraMist®
equipment-based
revenues was $2,945,000 and $669,000, respectively, representing an
increase of $2,276,000 or 340%
●
SteraMist®
BIT
Solution-based revenues was $732,000 and $259,000, respectively,
representing an increase of $473,000 or 183%
●
Service-based revenue was $615,000 and $672,000, respectively,
representing a decrease of $57,000 or 8%.
●
Domestic revenue was $3,446,000 and $1,288,000, respectively,
representing an increase of $2,158,000, or 168%.
●
International revenue was approximately $846,000 and $312,000,
respectively, representing an increase of $534,000 or
171%.
●
Gross margins were 66.1% compared to 71.3%. The lower gross profit
is attributable to the product mix in sales.
●
Income from operations was $1,096,000, compared to a Loss from
operations of ($188,000), representing an increase of
$1,284,000.
●
Net Income was $1,019,000, or $0.06 on a per share basis compared
to a Net loss of ($237,000), or ($0.02) on a per share basis,
representing an increase of $1,256,000.
●
EBIDTA was $1,274,000 compared to an adjusted net loss of ($5,000).
A table reconciling EBITDA to the appropriate GAAP measure is
included with the Company's financial information
below.
●
Cash provided from operations for the nine months ended September
30, 2020 and 2019 of $4,945,000, compared to cash used in
operations of ($573,000), respectively.
Balance sheet highlights as of September 30, 2020 and December 31,
2019
●
Cash and cash equivalents of approximately $5,885,000 and $897,000,
representing an increase of $4,988,000.
●
Working capital of $11,692,000 and ($1,266,000), representing an
increase of $12,958,000.
●
Shareholders’ equity of $13,251,000 and $890,000,
representing an increase of $12,361,000.
Current Business Highlights To Date
Revenues
●
Milestone reached in the third quarter of 2020 with total revenues
exceeding $21 million in a calendar year.
●
Year over year growth
in overall revenue through September 30th
of
$16,882,000 or 376%.
●
Year over year growth
SteraMist®
equipment
revenue through September 30th
of
$13,165,000 or 456%.
●
Year over year growth
SteraMist®
BIT
Solution revenue through September 30th
of
$2,931,000 or 509%.
●
Year over year growth
in service revenue through September 30th
of $786,000
or 76%.
Business Highlights
●
Increased demand on solution re-orders as disinfecting and
decontamination procedures have increased exponentially across the
world.
●
Saw an increase in Hospital-Healthcare customers purchasing
multiple SteraMist units in order to deploy throughout multiple
locations and/or areas within a facility.
●
Broke ground on installation of permanent fogging system into our
Frederick MD Facility.
●
Continued development and testing of the “SteraBot” and
launch of pilot program at Lithuanian University
Hospital.
●
Continued development of SteraPack with a tentative launch set for
first quarter 2021.
●
Launch of Commercial Division in response to increased demand in
Federal Government facilities and agencies, the aircraft (both
airplane and helicopter), manufacturing companies, automobile,
naval, education, retail, housing and recreation, and of course
emergency preparedness for counties and
cities.
●
SteraMist was featured in a United States Department of Agriculture
paper “Cold plasma-activated hydrogen peroxide aerosol on
populations of Salmonella Typhimurium and Listeria innocua and
quality changes of apple, tomato and cantaloupe during storage
– A pilot scale study” is authored by Dr. Xuetong Fan,
who has previously contributed to two prior studies regarding
direct produce application.
●
Issuance of a first Australian patent protecting use of its iHP
technology, and pursuing patent rights in diverse regions of the
world, encompassing the European Union, Brazil, Mexico, Korea,
China, India, and many other countries.
●
SteraMist was chosen to be a disinfection solution for the
2019-2020 PGA Champions Tour.
●
Increased demand of product and services has led to the hiring and
onboarding of additional employees to assist in a wide variety of
company operations, including but not limited to accounting,
procurement, customer satisfaction, and quality
control.
TOMI™ Environmental Solutions, Inc.: Innovating for a
safer world®
TOMI™ Environmental Solutions, Inc.
(NASDAQ:TOMZ)
is a global decontamination and infection prevention company,
providing environmental solutions for indoor surface disinfection
through the manufacturing, sales and licensing of its premier
Binary Ionization Technology® (BIT™) platform.
Invented under a defense grant in association with the Defense
Advanced Research Projects Agency (DARPA) of the U.S. Department of
Defense, BIT™ solution utilizes a low percentage
Hydrogen Peroxide as its only active ingredient to produce a fog of
ionized Hydrogen Peroxide (iHP™). Represented by the
SteraMist® brand of products, iHP™ produces a
germ-killing aerosol that works like a visual non-caustic
gas.
TOMI products are designed to service a broad spectrum of
commercial structures, including, but not limited to, hospitals and
medical facilities, cruise ships, office buildings, hotel and motel
rooms, schools, restaurants, meat and produce processing
facilities, military barracks, police and fire departments, and
athletic facilities. TOMI products and services have also
been used in single-family homes and multi-unit
residences.
TOMI develops training programs and application protocols for
its clients and is a member in good standing with The American
Biological Safety Association, The American Association of Tissue
Banks, Association for Professionals in Infection Control and
Epidemiology, Society for Healthcare Epidemiology of America,
America Seed Trade Association, and The Restoration Industry
Association.
For additional information, please visit http://www.tomimist.com/ or
contact us at [email protected].
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
Certain written and oral statements made by us may constitute
“forward-looking statements” as defined in the Private
Securities Litigation Reform Act of 1995 (the “Reform
Act”). Forward-looking statements are identified by such
words and phrases as “we expect,” “expected
to,” “estimates,” “estimated,”
“current outlook,” “we look forward to,”
“would equate to,” “projects,”
“projections,” “projected to be,”
“anticipates,” “anticipated,” “we
believe,” “could be,” and other similar phrases.
All statements addressing operating performance, events, or
developments that we expect or anticipate will occur in the future,
including statements relating to revenue growth, earnings,
earnings-per-share growth, or similar projections, are
forward-looking statements within the meaning of the Reform Act.
They are forward-looking, and they should be evaluated in light of
important risk factors that could cause our actual results to
differ materially from our anticipated results. The information
provided in this document is based upon the facts and circumstances
known at this time. We undertake no obligation to update these
forward-looking statements after the date of this
release.
Use of Non-GAAP Financial Measures
TOMI uses a non-GAAP financial measures in this release. Earnings
before interest, taxes, depreciation and amortization (EBITDA) is a
non-GAAP financial measure and is intended to serve as a supplement
to TOMI’s results provided in accordance with GAAP. TOMI
believes that such information may provide its investors a better
understanding of TOMI’s underlying operational performance,
business and performance trends.
Although TOMI believes that the use of non-GAAP financial measures
enhance its investors’ understanding of its business and
performance, TOMI’s use of non-GAAP financial measures should
not be considered an alternative to GAAP basis financial measures
and should be read in conjunction with the relevant GAAP financial
measures. Other companies in similar industries may define or
calculate non-GAAP financial measures differently than TOMI,
limiting their usefulness as a comparative measure. Because
of these limitations, the non-GAAP financial measure used in this
release should not be considered in isolation or as a substitute
for performance measures calculated in accordance with GAAP. A
reconciliation of the non-GAAP financial measures to the most
directly comparable GAAP measure is available in this news
release.
|
TOMI ENVIRONMENTAL SOLUTIONS, INC.
|
|
CONDENSED CONSOLIDATED BALANCE SHEET
|
|
ASSETS
|
|
|
|
Current
Assets:
|
September
30,
2020
(Unaudited)
|
|
|
Cash and Cash
Equivalents
|
$5,885,383
|
$897,223
|
|
Accounts Receivable
- net
|
3,504,284
|
1,494,658
|
|
Other
Receivables
|
157,487
|
-
|
|
Inventories
|
4,374,500
|
2,315,214
|
|
Vendor
Deposits
|
333,212
|
141,052
|
|
Prepaid
Expenses
|
376,758
|
187,664
|
|
Total
Current Assets
|
14,631,624
|
5,035,811
|
|
|
|
|
|
Property and
Equipment – net
|
1,111,342
|
1,367,864
|
|
|
|
|
|
Other
Assets:
|
|
|
|
Intangible Assets
– net
|
658,969
|
939,010
|
|
Operating Lease -
Right of Use Asset
|
642,738
|
674,471
|
|
Capitalized
Software Development Costs - net
|
62,852
|
94,278
|
|
Other
Assets
|
469,024
|
114,033
|
|
Total
Other Assets
|
1,833,583
|
1,821,792
|
|
Total
Assets
|
$17,576,549
|
$8,225,467
|
|
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|
|
|
Current
Liabilities:
|
|
|
|
Accounts
Payable
|
$2,149,988
|
$713,222
|
|
Accrued
Expenses and Other Current Liabilities
|
671,381
|
450,112
|
|
Accrued
Officers Compensation
|
40,050
|
-
|
|
Accrued
Interest
|
-
|
66,667
|
|
Current
Portion of Long-Term Operating Lease
|
78,723
|
71,510
|
|
Convertible
Notes Payable, net of discount of $0
|
|
|
|
at
December 31, 2020
|
-
|
5,000,000
|
|
Total
Current Liabilities
|
2,940,142
|
6,301,511
|
|
|
|
|
|
Long-Term
Liabilities:
|
|
|
|
Loan
Payable
|
410,700
|
|
|
Long-Term
Operating Lease, Net of Current Portion
|
974,311
|
1,034,413
|
|
Total
Long-Term Liabilities
|
1,385,011
|
1,034,413
|
|
Total
Liabilities
|
4,325,153
|
7,335,924
|
|
|
|
|
|
Commitments
and Contingencies
|
-
|
-
|
|
Shareholders’
Equity:
|
|
|
|
Cumulative
Convertible Series A Preferred Stock;
|
|
|
|
par value $0.01
per share, 1,000,000 shares authorized; 63,750 shares
issued
|
|
|
and
outstanding at September 30, 2020 and December 31,
2019
|
638
|
638
|
Cumulative
Convertible Series B Preferred Stock; $1,000 stated
value;
|
|
7.5%
Cumulative dividend; 4,000 shares authorized; none
issued
|
|
|
and
outstanding at September 30, 2020 and December 31,
2019
|
-
|
-
|
Common
stock; par value $0.01 per share, 250,000,000 shares
authorized;
|
|
16,748,513
and 15,587,552 shares issued and outstanding
|
|
|
at
September 30, 2020 and December 31, 2019,
respectively.
|
167,485
|
155,875
|
|
Additional
Paid-In Capital
|
49,287,039
|
44,232,274
|
|
Accumulated
Deficit
|
(36,203,766)
|
(43,499,244)
|
|
Total
Shareholders’ Equity
|
13,251,396
|
889,543
|
|
Total Liabilities
and Shareholders’ Equity
|
$17,576,549
|
$8,225,467
|
(1)
Share amounts have been retroactively restated to reflect the
Company’s reverse stock split, which was effected September
10, 2020. Refer to Note 11—Equity for further
information.
TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(UNAUDITED)
|
|
For The Three
Months Ended
|
For The Nine
Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales,
net
|
$4,291,589
|
$1,600,387
|
$21,373,504
|
$4,491,719
|
|
Cost
of Sales
|
1,455,568
|
460,008
|
8,484,580
|
1,616,680
|
|
Gross
Profit
|
2,836,021
|
1,140,379
|
12,888,924
|
2,875,039
|
|
|
|
|
|
|
|
Operating
Expenses:
|
|
|
|
|
|
Professional
Fees
|
227,560
|
82,945
|
418,516
|
297,349
|
|
Depreciation
and Amortization
|
177,279
|
182,689
|
521,486
|
539,070
|
|
Selling
Expenses
|
212,624
|
314,110
|
980,096
|
1,274,326
|
|
Research
and Development
|
44,862
|
88,137
|
245,443
|
249,373
|
|
Equity
Compensation Expense
|
10,621
|
-
|
307,686
|
87,033
|
|
Consulting
Fees
|
75,204
|
31,799
|
226,454
|
87,066
|
|
General
and Administrative
|
991,543
|
628,285
|
2,776,846
|
1,931,770
|
|
Total Operating
Expenses
|
1,739,693
|
1,327,965
|
5,476,527
|
4,465,987
|
|
Income (loss) from
Operations
|
1,096,328
|
(187,586)
|
7,412,397
|
(1,590,948)
|
|
|
|
|
|
|
|
Other Income
(Expense):
|
|
|
|
|
|
Amortization
of Debt Discounts
|
-
|
-
|
-
|
(17,534)
|
|
Interest
Income
|
762
|
773
|
2,347
|
2,432
|
|
Interest
Expense
|
(790)
|
(50,000)
|
(42,266)
|
(150,000)
|
|
Total Other Income
(Expense)
|
(28)
|
(49,227)
|
(39,919)
|
(165,102)
|
|
|
|
|
|
|
|
Income (loss)
before income taxes
|
1,096,300
|
(236,813)
|
7,372,478
|
(1,756,050)
|
|
Provision for
Income Taxes
|
77,000
|
-
|
77,000
|
-
|
|
Net Income
(loss)
|
$1,019,300
|
$(236,813)
|
$7,295,478
|
$(1,756,050)
|
|
|
|
|
|
|
|
Net income (loss)
Per Common Share
|
|
|
|
|
|
Basic
|
$0.06
|
$(0.02)
|
$0.44
|
$(0.11)
|
|
Diluted
|
$0.05
|
$(0.02)
|
$0.40
|
$(0.11)
|
|
|
|
|
|
|
|
Basic Weighted
Average Common Shares Outstanding
|
16,741,622
|
15,588,680
|
16,429,360
|
15,585,822
|
|
Diluted Weighted
Average Common Shares Outstanding
|
18,593,255
|
15,588,680
|
18,280,993
|
15,585,822
|
(1)
Share and per share amounts have been retroactively restated to
reflect the Company’s reverse stock split, which was effected
September 10, 2020. Refer to Note 11—Equity for further
information.
|
Reconciliation of Net Income to EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
For The Three
Months Ended
|
For The Nine
Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss)
|
$1,019,300
|
$(236,813)
|
$7,295,478
|
$(1,756,050)
|
|
|
|
|
|
|
|
Interest
Income
|
(762)
|
(773)
|
(2,347)
|
(2,432)
|
|
Interest
Expense
|
790
|
50,000
|
42,266
|
150,000
|
|
Depreciation
and Amortization
|
177,279
|
182,689
|
521,486
|
539,070
|
|
Provision
for Income Taxes (Note 17)
|
77,000
|
|
77,000
|
|
|
Other
|
-
|
-
|
-
|
17,534
|
|
EBITDA (Adjusted
Loss)
|
$1,273,607
|
$(4,897)
|
$7,933,883
|
$(1,051,878)
|
|
|
|
|
|
|
|
EBITDA
Margin
|
30%
|
0%
|
37%
|
-23%
|
INVESTOR
RELATIONS CONTACT
Harold Paul